MGD019
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MGD019, covering 2025-10-14 to 2025-10-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors [Phase 1]